News

Eden Unveils NAD+ Cream: A Prescription for Cellular Health

Eden Unveils NAD+ Cream: A Prescription for Cellular Health

Eden Launches Innovative NAD+ Face Cream

Eden, a leading health platform, has introduced a unique NAD+ 10% Face Cream formulated to support skin resilience and promote cellular wellness. This product is now available nationwide, allowing individuals to benefit from this advanced skincare solution through a prescription obtained via consultations with licensed medical providers.

Understanding the Benefits of NAD+

The NAD+ Face Cream, available in convenient 15 mL and 30 mL pump bottles, combines 10% nicotinamide adenine dinucleotide (NAD+), a naturally found molecule that contributes to energy processes within cells. By harnessing the power of NAD+, this cream aims to rejuvenate and energize the skin, providing a boost to overall skincare routines.

The Science Behind Cellular Wellness

As Dr. Bronwyn Mahtani, a member of Eden's Medical Advisory Board, notes, the increasing demand for skincare products that align with the latest research in cellular wellness is captivating consumers. This innovative formulation signifies a customized approach to skincare, accessible only through a consultation with a healthcare professional. Dr. Mahtani emphasizes the importance of personalization in skin support, ensuring that every individual's unique needs are met.

A Cautionary Note on Usage

Eden underlines that while NAD+ is recognized for its role in aging and cellular biology, the use of this ingredient in topical products is still a developing area. Individual responses to the NAD+ Face Cream may differ, and specific cosmetic or therapeutic results cannot be assured. It is crucial for users to integrate this product into a comprehensive skincare regimen that aligns with scientific insights.

Commitment to Accessible Healthcare Solutions

Josh Khan, President and Co-Founder of Eden, stated, "Our mission is centered on enhancing access to broad innovation through pharmacy-compounded treatments that patients can discuss with their healthcare providers. We are committed to launching products that reflect the continuous evolution of research and cater to the rising interest in mindful, medically guided wellness solutions." Through their platform, patients can acquire the NAD+ Face Cream exclusively through a prescription, which will be fulfilled and shipped by state-licensed compounding pharmacies.

About Eden

Eden is dedicated to connecting individuals with licensed healthcare professionals, compounding pharmacies, and nutritional solutions tailored to support metabolic health. By offering a streamlined online experience, Eden empowers patients to explore various personalized treatment options in a user-friendly manner, reinforcing their overall wellness journey.

Frequently Asked Questions

What is the main ingredient in the NAD+ Face Cream?

The cream contains 10% nicotinamide adenine dinucleotide (NAD+), which is key for cellular energy and skin vitality.

How can consumers access this product?

The NAD+ Face Cream is available exclusively through prescription after a consultation with a licensed medical provider via Eden's telehealth platform.

Who can prescribe the NAD+ Face Cream?

Licensed healthcare professionals can prescribe the cream, ensuring personalized guidance for every patient.

Is the use of NAD+ in topical creams widely researched?

While NAD+ is known for its benefits in cellular processes, its application in skincare is an emerging research area.

What is Eden's mission regarding health products?

Eden aims to enhance access to innovative, pharmacy-compounded health solutions that foster collaboration between patients and their providers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 220

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 166

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 125

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
Tenax Sued: Investors Face Class Action Over TNX-103

Updated Category News Views 140

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 76

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 58

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
CassTime's AI Solution Eases Global Parts Market Strains

Updated Category News Views 130

Driving Innovation in the Auto Aftermarket When car parts become a global jigsaw puzzle, you need more than wrenches to solve it. Enter CassTime with its AI-driven 'T+D Solution'—a tangible answer to the woes of data matching and repair capability bottlenecks plaguing the automotive aftermarket worldwide. Taming the Global Parts Beast Pull back the curtain on AAPEX 2026...

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 160

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 187

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 156

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Intercom Grows With New Brand Identity

Updated Category News Views 39

Class Intercom's Evolution Reflects a Broader Vision Today's education world ain't what it used to be, and Class Intercom seems to be right in the thick of the transformation. They're not just sticking to their old ways of handling school social media. Nope, they’re expanding their reach with a brand new chapter. The Power of Authentic School Storytelling Class Intercom...

Continue Reading
Reichman Jorgensen Welcomes Expertise of Nathan Mammen as Partner

Updated Category News Views 227

Reichman Jorgensen Welcomes Nathan Mammen to the Team Reichman Jorgensen Lehman & Feldberg LLP (RJLF), an esteemed national trial boutique, proudly announces the addition of Nathan Mammen as a partner in its Washington, D.C. office. Mammen, an accomplished intellectual property litigator and appellate lawyer, brings over two decades of experience to the firm. Experience...

Continue Reading
Tokyo Lifestyle Co., Ltd. Achieves Remarkable Fiscal Growth

Updated Category News Views 164

Tokyo Lifestyle Co., Ltd.'s Impressive Growth Report Tokyo Lifestyle Co., Ltd. (NASDAQ: TKLF), a prominent retailer and wholesaler of Japanese beauty and health products, has announced impressive financial results during the first half of fiscal year 2025. This growth reflects their strategic focus on increasing market presence and profitability despite a competitive...

Continue Reading
Pierre Fitzgibbon Joins Volt-Age Program Advisory Board

Updated Category News Views 212

Pierre Fitzgibbon Appointed to Volt-Age Advisory Board Concordia University’s esteemed Volt-Age program has taken a significant step forward by inviting Pierre Fitzgibbon, who previously served as the Minister for Economy, Innovation, and Energy, to its advisory board. This move aims to leverage Fitzgibbon's extensive experience to steer the strategic direction of the...

Continue Reading
EZCORP Restructures Its Acquisition Strategy for Growth

Updated Category News Views 138

EZCORP's Strategic Shift in Acquisition Plans Recently, EZCORP, Inc. (NASDAQ: EZPW), a premier provider of pawn loans throughout the Americas, made headlines by ending its acquisition deal with Presta Dinero, S.A. de C.V. This pivotal decision involves the cancellation of plans to acquire 53 stores in Mexico, first announced earlier. Leadership's Perspective on the...

Continue Reading